期刊
JOURNAL OF CLINICAL PATHOLOGY
卷 60, 期 3, 页码 307-310出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jcp.2005.035717
关键词
-
类别
Aim: Peroxisome proliferator-activated receptor gamma (PPAR gamma) has emerged as a potential therapeutic target in several types of cancer. In ovarian carcinomas, limited and conflicting data on PPARc protein expression have been reported. Methods: The immunoexpression of PPAR gamma and its putative target cyclo-oxygenase 2 (COX2) was investigated in tumour tissues from 80 patients with primary and corresponding recurrent ovarian serous carcinomas after conventional platinum-based chemotherapy. Results: PPARc expression was observed in 29% of primary and recurrent carcinomas. In the recurrent tumours, PPARc expression inversely correlated with COX2 overexpression in both chemosensitive (p = 0.02) and chemoresistant (p = 0.04) carcinomas. Conclusions: The data indicate that PPARc may represent a potential target for second-line treatment in ovarian cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据